ANTIBODY AND B7/BB1-MEDIATED LIGATION OF THE CD28 RECEPTOR INDUCES TYROSINE PHOSPHORYLATION IN HUMAN T-CELLS

被引:144
作者
VANDENBERGHE, P
FREEMAN, GJ
NADLER, LM
FLETCHER, MC
KAMOUN, M
TURKA, LA
LEDBETTER, JA
THOMPSON, CB
JUNE, CH
机构
[1] USN,MED RES INST,IMMUNE CELL BIOL PROGRAM,MAIL STOP 44,BETHESDA,MD 20814
[2] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV TUMOR IMMUNOL,BOSTON,MA 02115
[3] UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104
[4] UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109
[5] ONCOGEN CORP,SEATTLE,WA 98121
[6] UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109
[7] UNIV MICHIGAN,DEPT MED,ANN ARBOR,MI 48109
[8] UNIV MICHIGAN,DEPT MICROBIOL IMMUNOL,ANN ARBOR,MI 48109
关键词
D O I
10.1084/jem.175.4.951
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD28 is an adhesion receptor expressed as a 44-kD dimer on the surface of a major subset of human T cells. The CD28 receptor regulates the production of multiple lymphokines, including interleukin 2 (IL-2), by activation of a signal transduction pathway that is poorly understood. Here we show that ligation of CD28 by a monoclonal antibody (mAb) or by a natural ligand, B7/BB1, induces protein tyrosine phosphorylation that is distinct from T cell receptor (TCR)-induced tyrosine phosphorylation. CD28-induced protein tyrosine phosphorylation was greatly enhanced in cells that had been preactivated by ligation of the TCR, or by pretreatment with phorbol esters. Rapid and prolonged tyrosine phosphorylation of a single substrate, pp100, was induced in T cells after interaction with B7/BB1 presented on transfected Chinese hamster ovary (CHO) cells. Anti-B7 mAb inhibited B7/BB1 receptor-induced tyrosine phosphorylation, indicating that B7-CD28 interaction was required. CD28-induced tyrosine phosphorylation was independent of the TCR because it occurred in a variant of the Jurkat T cell line that does not express the TCR. Herbimycin A, a protein tyrosine kinase inhibitor, could prevent CD28-induced tyrosine phosphorylation and CD28-induced IL-2 production in normal T cells. The simultaneous crosslinking of CD28 and CD45, a tyrosine phosphatase, could prevent tyrosine phosphorylation of pp100. These results suggest that specific tyrosine phosphorylation, particularly of pp100, occurs directly as a result of CD28 ligand binding and is involved in transducing the signal delivered through CD28 by accessory cells that express the B7/BB1 receptor. Thus, this particular form of signal transduction may be relevant to lymphokine production and, potentially may provide a means to study the induction of self-tolerance, given the putative role of the costimulatory signal in the induction of T cell activation or anergy.
引用
收藏
页码:951 / 960
页数:10
相关论文
共 40 条
[1]   HUMAN T-CELL ACTIVATION - DIFFERENTIAL RESPONSE TO ANTI-CD28 AS COMPARED TO ANTI-CD3 MONOCLONAL-ANTIBODIES [J].
BJORNDAHL, JM ;
SUNG, SSJ ;
HANSEN, JA ;
FU, SM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (05) :881-887
[2]   REGULATION OF INTERLEUKIN-2 GENE ENHANCER ACTIVITY BY THE T-CELL ACCESSORY MOLECULE CD28 [J].
FRASER, JD ;
IRVING, BA ;
CRABTREE, GR ;
WEISS, A .
SCIENCE, 1991, 251 (4991) :313-316
[3]  
FREEDMAN AS, 1987, J IMMUNOL, V139, P3260
[4]   SELECTIVE INDUCTION OF B7/BB-1 ON INTERFERON-GAMMA STIMULATED MONOCYTES - A POTENTIAL MECHANISM FOR AMPLIFICATION OF T-CELL ACTIVATION THROUGH THE CD28 PATHWAY [J].
FREEDMAN, AS ;
FREEMAN, GJ ;
RHYNHART, K ;
NADLER, LM .
CELLULAR IMMUNOLOGY, 1991, 137 (02) :429-437
[5]  
FREEMAN GJ, 1989, J IMMUNOL, V143, P2714
[6]   B-CELL SURFACE ANTIGEN-B7 PROVIDES A COSTIMULATORY SIGNAL THAT INDUCES T-CELLS TO PROLIFERATE AND SECRETE INTERLEUKIN-2 [J].
GIMMI, CD ;
FREEMAN, GJ ;
GRIBBEN, JG ;
SUGITA, K ;
FREEDMAN, AS ;
MORIMOTO, C ;
NADLER, LM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (15) :6575-6579
[7]   HUMAN T-CELL ACTIVATION .2. A NEW ACTIVATION PATHWAY USED BY A MAJOR T-CELL POPULATION VIA A DISULFIDE-BONDED DIMER OF A 44-KILODALTON POLYPEPTIDE (9.3 ANTIGEN) [J].
HARA, T ;
FU, SM ;
HANSEN, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (06) :1513-1524
[8]  
HSI ED, 1989, J BIOL CHEM, V264, P10836
[9]  
JUNE CH, 1989, J IMMUNOL, V143, P153
[10]  
JUNE CH, 1990, J IMMUNOL, V144, P1591